Ghana Gives Go Ahead To Oxford University Malaria Vaccine
A malaria vaccine called R21/Matrix-M, which was developed in collaboration with the University of Oxford as well as a manufacturer of vaccines and immunological...
Research Pins Down New Target To Get Rid of Blood Cancer
A worldwide consortium that comprises biomedical researchers co-led by Alexander Bick, MD, PhD, at the Vanderbilt University Medical Centre, has come up with a...
Customised Blood Pressure Treatment Can Get More Protection
A study from Sweden has gone on to show that patients who have been treated with drugs that are used to lower blood pressure...
Elevating Vaccine Stability Through Predicting mRNA Degrades
Messenger ribonucleic acid (mRNA) as a therapeutic method is gaining traction due to its ease of production and promising results.
mRNA-based vaccines, for example, have...
Microbial Fermentation Tech Market To Go Beyond $56b In 2023
The worldwide microbial fermentation technology market is anticipated to overshoot a value of $57,974.87 million by 2033, as per a report.
Hence, the projected compound...
Novel Therapy Uses Blood Cells of Patients To Fight Tumour
Adoptive cell therapy has gone on to become a promising immunotherapy tool that can be used to help in the treatment of advanced melanoma....
FDA Backs Randomized Controlled Trials For Speedy Drug Nods
In a significant update to its existing policies when it comes to conducting clinical trials so as to support an accelerated approval for oncology...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...



























